Transitioning selexipag to oral treprostinil in patients with pulmonary artery hypertension

There are no prospective studies or guidelines describing transition between selexipag and oral treprostinil. We present two different transition strategies from selexipag to oral treprostinil, one started inpatient and then completed at home, and one completely under outpatient settings. Neither pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Arevalo, Carlo, White, R.James, Lachant, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038566/
https://www.ncbi.nlm.nih.gov/pubmed/35494550
http://dx.doi.org/10.1016/j.rmcr.2022.101646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038566/
https://www.ncbi.nlm.nih.gov/pubmed/35494550
http://dx.doi.org/10.1016/j.rmcr.2022.101646

Ejemplares similares